These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Breaking down the barriers: siRNA delivery and endosome escape. Dominska M; Dykxhoorn DM J Cell Sci; 2010 Apr; 123(Pt 8):1183-9. PubMed ID: 20356929 [TBL] [Abstract][Full Text] [Related]
3. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. Aigner A J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079 [TBL] [Abstract][Full Text] [Related]
4. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA. Liu B Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766 [TBL] [Abstract][Full Text] [Related]
5. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S; Benter I Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774 [TBL] [Abstract][Full Text] [Related]
6. RNA interference (RNAi) in hematology. Scherr M; Steinmann D; Eder M Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462 [TBL] [Abstract][Full Text] [Related]
7. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials. DeVincenzo JP Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462 [TBL] [Abstract][Full Text] [Related]
8. Dissecting RNA-interference pathway with small molecules. Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509 [TBL] [Abstract][Full Text] [Related]
11. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. Gary DJ; Puri N; Won YY J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702 [TBL] [Abstract][Full Text] [Related]
12. Short interfering RNA (siRNA): tool or therapeutic? Cejka D; Losert D; Wacheck V Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204 [TBL] [Abstract][Full Text] [Related]
13. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook. Shukla S; Sumaria CS; Pradeepkumar PI ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313 [TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
16. RNA interference: new mechanisms for targeted treatment? Woessmann W; Damm-Welk C; Fuchs U; Borkhardt A Rev Clin Exp Hematol; 2003 Sep; 7(3):270-91. PubMed ID: 15024970 [TBL] [Abstract][Full Text] [Related]
17. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing. Lee SH; Chung BH; Park TG; Nam YS; Mok H Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937 [TBL] [Abstract][Full Text] [Related]
18. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. Hoelters J; Ciccarella M; Drechsel M; Geissler C; Gülkan H; Böcker W; Schieker M; Jochum M; Neth P J Gene Med; 2005 Jun; 7(6):718-28. PubMed ID: 15712343 [TBL] [Abstract][Full Text] [Related]
19. Nonviral in vivo delivery of therapeutic small interfering RNAs. Aigner A Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447 [TBL] [Abstract][Full Text] [Related]
20. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]